Stay updated with breaking news from Thomas Scriba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A vaccine against tuberculosis, the world’s deadliest infectious disease, has never been closer to reality, with the potential to save millions of lives. But its development slowed after its corporate owner focused on more profitable vaccines.
A vaccine against tuberculosis has never been closer to reality. But its development slowed after its corporate owner focused on more profitable vaccines.
If the next steps are successful, M72 would be the first new vaccine in a century to target tuberculosis, a disease that killed 1.6 million people in 2021.
A clinical trial for a new Tuberculosis (TB) vaccine is to be conducted in South Africa.
A tuberculosis vaccine under development by the Gates Foundation could reduce TB by 50%. "It's a really big deal."